颈动脉干预后再狭窄与同侧复发性卒中的关系:系统综述与Meta分析
该系统综述纳入11项随机对照试验(RCT)报告颈动脉内膜剥脱术(CEA)或颈动脉支架置入术(CAS)后>70%再狭窄(和/或闭塞)的发生率,9项RCT报告晚期同侧卒中率。Meta分析显示,CAS后无症状>70%再狭窄患者晚期同侧卒中率极低(0.8%,中位50个月),而CEA后无症状>70%再狭窄患者晚期同侧卒中风险显著高于无再狭窄者(校正后5.2% vs 1.5%,OR 4.77),但绝对风险仅约5%(中位37个月)。
要点
- CAS后无症状>70%再狭窄患者晚期同侧卒中率仅0.8%(中位50个月)。
- CEA后无症状>70%再狭窄患者晚期同侧卒中风险显著高于无再狭窄者(OR 4.77)。
- CAS后97%、CEA后85%的晚期同侧卒中出现于无显著再狭窄或闭塞的患者。
核心结论
- CAS后未治疗的无症状>70%再狭窄患者晚期同侧卒中率极低(0.8%,中位50个月)。
- CEA后未治疗的无症状>70%再狭窄患者晚期同侧卒中风险显著高于无再狭窄者,但37个月时仅约5%。
- CAS后97%和CEA后85%的晚期同侧卒中出现于无显著再狭窄或闭塞证据的患者。
研究设计与样本
- 系统综述纳入11项RCT报告CEA/CAS后>70%再狭窄(和/或闭塞)发生率,9项RCT报告晚期同侧卒中率。
- 采用比例Meta分析和随访终点比值比(OR)。
主要发现
- 任何CEA后>70%再狭窄加权发生率为5.8%(中位47个月;11项RCT;4249例患者)。
- 补片CEA后>70%再狭窄发生率为4.1%(中位32个月;5项RCT;1078例患者)。
- CAS后>70%再狭窄发生率为10%(中位62个月;5项RCT;2716例患者)。
- 4项RCT(1964例患者)中,CAS后>70%再狭窄(或闭塞)患者晚期同侧卒中1/125(0.8%),无显著再狭窄者37/1839(2.0%)(OR 0.87;95%CI 0.24-3.21;p=.8339),中位50个月。
- 7项RCT(2810例患者)中,CEA后>70%再狭窄(或闭塞)患者晚期同侧卒中13/141(9.2%),无显著再狭窄者33/2669(1.2%)(OR 9.02;95%CI 4.70-17.28;p<.0001),中位37个月。
临床怎么用
- CAS后无症状>70%再狭窄的晚期同侧卒中绝对风险极低,支持对此类患者采取保守监测策略。
- CEA后无症状>70%再狭窄与晚期同侧卒中风险升高相关,但绝对风险仅约5%(37个月),需个体化评估干预指征。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Do asymptomatic restenoses > 70% after carotid endarterectomy (CEA) and carotid stenting (CAS) increase the risk of late ipsilateral stroke? METHODS: Systematic review identified 11 randomised controlled trials (RCTs) reporting rates of restenosis > 70% (and/or occlusion) in patients who had undergone CEA/CAS for the treatment of primary atherosclerotic disease, and nine RCTs reported late ipsilateral stroke rates. Proportional meta-analyses and odds ratios (OR) at end of follow-up were performed. RESULTS: The weighted incidence of restenosis > 70% was 5.8% after "any" CEA, median 47 months (11 RCTs; 4249 patients); 4.1% after patched CEA, median 32 months (5 RCTs; 1078 patients), and 10% after CAS, median 62 months (5 RCTs; 2716 patients). In four RCTs (1964 patients), one of 125 (0.8%) with restenosis > 70% (or occlusion) after CAS suffered late ipsilateral stroke over a median 50 months, compared with 37 of 1839 (2.0%) in CAS patients with no significant restenosis (OR 0.87; 95% CI 0.24-3.21; p = .8339). In seven RCTs (2810 patients), 13 out of 141 (9.2%) with restenosis > 70% (or occlusion) after CEA suffered late ipsilateral stroke over a median 37 months, compared with 33 out of 2669 (1.2%) in patients with no significant restenoses (OR 9.02; 95% CI 4.70-17.28; p < .0001). Following data correction to exclude patients whose surveillance scan showed no evidence of restenosis > 70% before stroke onset, the prevalence of stroke ipsilateral to an untreated asymptomatic > 70% restenosis was seven out of 135 (5.2%) versus 40 out of 2704 (1.5%) in CEA patients with no significant restenosis (OR 4.77; 95% CI 2.29-9.92). CONCLUSIONS: CAS patients with untreated asymptomatic > 70% restenosis had an extremely low rate of late ipsilateral stroke (0.8% over 50 months). CEA patients with untreated, asymptomatic > 70% restenosis had a significantly higher risk of late ipsilateral stroke (compared with patients with no restenosis), but this was only 5% at 37 months. Overall, 97% of all late ipsilateral strokes after CAS and 85% after CEA occurred in patients without evidence of significant restenosis or occlusion.
引用
- Kumar R, Batchelder A, Saratzis A, et al. Restenosis after Carotid Interventions and Its Relationship with Recurrent Ipsilateral Stroke: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2017. PMID: 28363431. doi:10.1016/j.ejvs.2017.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。